Ching Victor, Hay Karen, Hui Ivan, Vandeleur Ann, Har Prisca, Rahman Tony, Alghamry Alaa
Internal Medicine Services, The Prince Charles Hospital, Brisbane, Queensland, Australia.
Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Intern Med J. 2025 Mar;55(3):467-473. doi: 10.1111/imj.16616. Epub 2024 Dec 24.
Iron deficiency anaemia (IDA) related to occult gastrointestinal tract (GIT) blood loss is associated with high rates of GIT malignancies. Major society guidelines recommend bidirectional endoscopic evaluation for all men and post-menopausal women with newly diagnosed, unexplained IDA. However, in patients prescribed direct oral anticoagulants (DOACs), the endoscopic yield, specifically the rate of high-risk findings, including colorectal cancers (CRCs) and advanced adenomas (AAs), is unknown.
Our aim is to determine the endoscopic yield, specifically the prevalence of these high-risk findings in patients presenting with new-onset unexplained IDA while on a DOAC.
This is a single-centre, retrospective analysis performed at a tertiary hospital in Australia. Between January 2015 and July 2019, 178 consecutive patients underwent endoscopic evaluation for IDA while prescribed a DOAC. Patient demographics, laboratory data, medications and endoscopic findings were summarised and compared by diagnostic yield. Associations were explored using logistic regression analysis.
CRCs were present in 2/178 (1.1% (95% confidence interval (CI): 0.1-4.0)) patients. AAs were found in 35/178 (19.6% (95% CI: 14.1-26.3)) patients. The most common AAs were tubular adenomas (45.7%), tubulovillous (31.4%) and sessile serrated adenomas (14.2%). Older age (P = 0.013) and lower ferritin levels (P = 0.009) were associated with the presence of high-risk findings.
In patients presenting with new-onset, unexplained IDA while on a DOAC, the prevalence of CRCs is lower than previously reported in studies involving populations not prescribed DOACs. Conversely, there is a higher incidence of AAs, including high-risk histological features, such as tubulovillous adenomas and sessile serrated polyps.
与隐匿性胃肠道失血相关的缺铁性贫血(IDA)与胃肠道恶性肿瘤的高发生率相关。主要学会指南建议对所有新诊断的、不明原因IDA的男性和绝经后女性进行双向内镜评估。然而,在服用直接口服抗凝剂(DOACs)的患者中,内镜检查的阳性率,特别是包括结直肠癌(CRC)和高级别腺瘤(AA)在内的高危发现率尚不清楚。
我们的目的是确定在服用DOAC的新发不明原因IDA患者中内镜检查的阳性率,特别是这些高危发现的患病率。
这是在澳大利亚一家三级医院进行的单中心回顾性分析。2015年1月至2019年7月期间,178例连续患者在服用DOAC的同时接受了IDA的内镜评估。通过诊断阳性率总结并比较患者的人口统计学、实验室数据、用药情况和内镜检查结果。使用逻辑回归分析探索相关性。
178例患者中有2例(1.1%(95%置信区间(CI):0.1 - 4.0))患有CRC。178例患者中有35例(19.6%(95%CI:14.1 - 26.3))发现有AA。最常见的AA是管状腺瘤(45.7%)、管状绒毛状腺瘤(31.4%)和无蒂锯齿状腺瘤(14.2%)。年龄较大(P = 0.013)和铁蛋白水平较低(P = 0.009)与高危发现的存在相关。
在服用DOAC的新发不明原因IDA患者中,CRC的患病率低于先前在未服用DOAC人群的研究中报告的患病率。相反,AA的发生率较高,包括具有高危组织学特征的,如管状绒毛状腺瘤和无蒂锯齿状息肉。